Consequently, two trial experiments for measuring human motions are implemented to validate the feasibility and effectiveness of the parallel-legged accelerometer.
This sixth article in the series (see Box) discusses different types of outcomes and their suitability for pragmatic trials, design choices for measuring these outcomes, and their implications and challenges.
The largest value of FVC (or FEV1) from acceptable trials was used for measuring FVC (or FEV1) (Statistics Canada 2010a, 2011).
After inducing TI, only animals that showed a startle to at least one visual or sound stimulus trial were taken for measuring the startle response.
In terms of methodology, randomized trials with standardized methods for measuring incidence of sharps injuries would provide better quality evidence relative to currently available evidence.
As precise identification of the presence of treatment effect modification requires a test of subgroup/treatment effect interaction, currently only two designs for controlled trials are well suited for measuring treatment modifier effects [ 23, 28, 29].
With drugs, patients are up-titrated to the doses used in major outcome trials without the need for measuring symptomatic response or predictors of outcome in routine clinical settings.
4 9 The two trials used generic instruments for measuring quality of life, which are less sensitive to changes in health related quality of life resulting from a particular outcome or condition.
During the trial, the routine method for measuring levels of folate was changed.
As the Patient Generated Index (PGI) permits participants to define what matters most to them and then rate the change in those domains, its use would improve the relevance of outcome measurement in trials generally as well as for measuring recovery in individuals [ 21, 22].
